Cargando…

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis

BACKGROUND: The high mobility group box 1 (HMGB1) is the prototype of alarmin protein released by stressed or dying cells. The redox state of this protein confers different functions in the regulation of inflammation and immune response. AIM: Determine the kinetics, cellular sources and function of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-Pando, Rogelio, Barrios-Payán, Jorge, Mata-Espinosa, Dulce, Marquina-Castillo, Brenda, Hernández-Ramírez, Diego, Botasso, Oscar Adelmo, Isabel Bini, Estela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511675/ https://www.ncbi.nlm.nih.gov/pubmed/26201072 http://dx.doi.org/10.1371/journal.pone.0133200

Ejemplares similares

Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

The Influence of Sex Steroid Hormones in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Bini, Estela Isabel, et al.
Publicado: (2014)

The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary Tuberculosis
por: Islas-Weinstein, Leon, et al.
Publicado: (2021)

Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
por: Zetter, Mario, et al.
Publicado: (2019)

The Therapeutic Effect of Intranasal Administration of Dexamethasone in Neuroinflammation Induced by Experimental Pulmonary Tuberculosis
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2021)

A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies
por: Rodríguez-Flores, Edén M., et al.
Publicado: (2019)

Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cells
por: Cribb, Pamela, et al.
Publicado: (2017)

Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity
por: Hernández-Bustamante, Israel, et al.
Publicado: (2023)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
por: Mata-Espinosa, Dulce, et al.
Publicado: (2023)

Targeted RNA-Seq Reveals the M. tuberculosis Transcriptome from an In Vivo Infection Model
por: Cornejo-Granados, Fernanda, et al.
Publicado: (2021)

Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2022)

Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of Mycobacterium tuberculosis strain infection
por: Lozano-Ordaz, Vasti, et al.
Publicado: (2023)

Profiling the immune response to Mycobacterium tuberculosis Beijing family infection: a perspective from the transcriptome
por: María Irene, Cerezo-Cortés, et al.
Publicado: (2021)

Experimental Pulmonary Tuberculosis in the Absence of Detectable Brain Infection Induces Neuroinflammation and Behavioural Abnormalities in Male BALB/c Mice
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2020)

Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
por: Segura-Cerda, Cristian Alfredo, et al.
Publicado: (2020)

BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
por: Segura-Cerda, Cristian Alfredo, et al.
Publicado: (2020)

In Vitro, In Vivo and In Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis
por: Palacios, Jacqueline Barrios, et al.
Publicado: (2022)

Two murine models of sepsis: immunopathological differences between the sexes—possible role of TGFβ1 in female resistance to endotoxemia
por: Bojalil, Rafael, et al.
Publicado: (2023)

Induction of bone formation in abdominal implants constituted by collagen sponges embedded with plant-based human transforming growth factor family proteins in ectopic dog model
por: Jacinto-Tinajero, Juan Carlos, et al.
Publicado: (2014)

Effect of Low Doses of Dexamethasone on Experimental Pulmonary Tuberculosis
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2023)

Close Related Drug-Resistance Beijing Isolates of Mycobacterium tuberculosis Reveal a Different Transcriptomic Signature in a Murine Disease Progression Model
por: Cerezo-Cortés, María Irene, et al.
Publicado: (2022)

The ctpF Gene Encoding a Calcium P-Type ATPase of the Plasma Membrane Contributes to Full Virulence of Mycobacterium tuberculosis
por: Maya-Hoyos, Milena, et al.
Publicado: (2022)

Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment
por: Jiménez-Arellanes, Adelina, et al.
Publicado: (2013)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
por: Zatarain-Barrón, Zyanya Lucia, et al.
Publicado: (2020)

Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis
por: García-Martínez, Mariano, et al.
Publicado: (2019)

Detection of Mycobacterial DNA in Human Bone Marrow
por: González-Escalada, Alba, et al.
Publicado: (2023)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019)

High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005)

Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis
por: Peláez Coyotl, Erika A., et al.
Publicado: (2020)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
por: Abdulahad, Deena A, et al.
Publicado: (2011)

Expression and purification of functional HMGB1 A box by fusion with SUMO
por: GE, WEN-SONG, et al.
Publicado: (2015)

HMGB1 and injury amplification
por: Huebener, Peter, et al.
Publicado: (2015)

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
por: Chen, Qingjie, et al.
Publicado: (2016)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
por: Liu, Wenjing, et al.
Publicado: (2023)

Protective Effect of a Lipid-Based Preparation from Mycobacterium smegmatis in a Murine Model of Progressive Pulmonary Tuberculosis
por: García, Maria de los Angeles, et al.
Publicado: (2014)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
por: Tirado, Yanely, et al.
Publicado: (2015)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
por: Yuan, Shunling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g7dsllf29d1grfo1b1ego0ns4t